Tadalafil Tablet, Film Coated
Product Images NDC 72789-430

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 72789-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789430 Label (72789430)

This is not-available.*

FDA Label Image

Chemical Structure (Tadalafil 1)

FDA Label Image

Tadalafil-tablets-figure-1 (Tadalafil 2)

This text mentions the difference in blood pressure values between Tadalafil and Placebo, specifically for standing systolic and diastolic blood pressure, as well as supine systolic and diastolic blood pressure over time (in hours). It seems to be a comparison of the impact of Tadalafil on blood pressure compared to a placebo.*

FDA Label Image

Tadalafil-tablets-figure-2 (Tadalafil 3)

FDA Label Image

Tadalafil-tablets-figure-3 (Tadalafil 4)

This text contains information about a study comparing the effects of different treatments on systolic blood pressure at different time points. The treatments evaluated include tadalafil and doxazosin at various doses and timings. The data presented may be useful for analyzing the impact of these medications on blood pressure regulation.*

FDA Label Image

Tadalafil-tablets-figure-4 (Tadalafil 5)

This text shows a table displaying plasma Tadalafil concentration in micrograms per liter over time for different doses and administration schedules. The data includes a single 20-mg dose, a single 5-mg dose, and a once-daily 5-mg dose for 5 consecutive days. Time points of measurement are at 12, 24, 36, 48, 60, 72, 84, 96, 108, and 120 hours post-administration. These values can be used for pharmacokinetic analysis of Tadalafil.*

FDA Label Image

Table 5 (Tadalafil 6)

FDA Label Image

Table 6 (Tadalafil 7)

FDA Label Image

Tadalafil-tablets-figure-7 (Tadalafil 8)

The text appears to show data related to the LS mean change from baseline over weeks of therapy for both the placebo and finasteride groups. It is indicating statistical significance levels for the data.*

FDA Label Image

Image 8 (Tadalafil 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.